John W. Smither serves as Executive at KYTHERA BIOPHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, John W. Smither has executed 111 insider transactions totaling $8.7M, demonstrating a bearish approach to their equity position. Their most recent transaction on Nov 6, 2013 involved exercising options for 9,000 shares valued at $12.2K.
John W. Smither currently holds 15,300 shares of KYTHERA BIOPHARMACEUTICALS INC (KYTH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John W. Smither has been a net seller of KYTH stock. They have purchased $0 and sold $8.7M worth of shares.
John W. Smither's most recent insider trade was on Nov 6, 2013, when they sold 9,000 shares at $1.35 per share.
Get notified when new Form 4 filings are submitted
| $30.03 |
| Discretionary |
| Sep 10, 2013 | KYTH | $40.5K | Option Exercise | 30,000 | $1.35 | Discretionary |
| Sep 9, 2013 | KYTH | $300.0K | Sale | 10,000 | $30.00 | Discretionary |
| Sep 9, 2013 | KYTH | $13.5K | Option Exercise | 10,000 | $1.35 | Discretionary |
| Aug 1, 2013 | KYTH | $268.0K | Sale | 10,000 | $26.80 | Discretionary |
| Aug 1, 2013 | KYTH | $13.5K | Option Exercise | 10,000 | $1.35 | Discretionary |
| Jun 17, 2013 | KYTH | $156.0K | Sale | 6,000 | $26.00 | Discretionary |
| Jun 17, 2013 | KYTH | $8.1K | Option Exercise | 6,000 | $1.35 | Discretionary |
| May 1, 2013 | KYTH | $96.4K | Sale | 4,000 | $24.11 | Discretionary |
| May 1, 2013 | KYTH | $5.4K | Option Exercise | 4,000 | $1.35 | Discretionary |